IL10 and Alzheimer disease: Notably, whereas IL-10 is increased [112], the levels of LXA4 [113] and EP4 [111] are reduced in human AD, indicating that targeting missing inflammatory mediators may be a better approach to restore the balance between pro- and anti-inflammatory signals in the immune responses during aging and AD.